logo
Introduction
Aspirin and other anti-inflammatory drugs
Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
Unusual effects of aspirin on ticlopidine induced thrombolysis
Epidemiology of chronic rhinosinusitis
Perennial allergic rhinitis and keratoconjunctivitis
Haemopoietic mechanisms in nasal polyposis and asthma
United airways disease: therapeutic aspects
Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways
Lipoxins and other arachidonate derived mediators in bronchial asthma
Clinical features and diagnosis of aspirin induced asthma
Genetics of aspirin induced asthma
Inhaled transmembrane ion transport modulators and non-steroidal anti-inflammatory drugs in asthma
Oxidant stress in asthma
The importance of COX-2 inhibition for aspirin induced asthma
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact
New evidence of inflammation in asthma
Allergic reactions to drugs: involvement of T cells
The aspirin disease
Aspirin induced adverse skin reactions: new pathophysiological aspects
Hypersensitivity to pyrazolones
Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies
Nasal polyposis, eosinophil dominated inflammation, and allergy
Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?
Surgical treatment of nasal polyposis in patients with aspirin intolerance